VF
QNRX

Virtu Financial’s Quoin Pharmaceuticals QNRX Stock Holding History

Virtu Financial’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-719
Closed -$13K – 1956
2024
Q3 		$13K Buy
+719
New +$15.1K ﹤0.01% 1171
2024
Q2 		– Sell
-879
Closed -$29K – 1784
2024
Q1 		$29K Buy
+879
New +$86.7K ﹤0.01% 1112
2023
Q2 		– Sell
-352
Closed -$70K – 1941
2023
Q1 		$70K Buy
+352
New +$172K 0.01% 1046
2022
Q4 		– Sell
-71
Closed -$67K – 2048
2022
Q3 		$67K Buy
+71
New +$146K 0.01% 1150
2022
Q2 		– Sell
-8
Closed -$57K – 1974
2022
Q1 		$57K Buy
+8
New +$59.8K ﹤0.01% 1096
2021
Q2 		– Sell
-1
Closed -$64K – 1973
2021
Q1 		$64K Buy
+1
New +$69.8K ﹤0.01% 1400

Other funds holding QNRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Virtu Financial's QNRX Position: Q4 2024 in Review

Virtu Financial sold out of Quoin Pharmaceuticals (QNRX) in Q4 2024, closing a stake of 719 shares — an estimated $13K sold.

Virtu Financial first reported a position in QNRX in Q1 2021 and held it in 6 quarters. The position peaked at $70K in Q1 2023. 13 funds tracked by Wall St. Rank hold QNRX as of Q4 2024.

  • Virtu Financial reported no remaining Quoin Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Virtu Financial sold 719 Quoin Pharmaceuticals shares in Q4 2024, an estimated $13K.
  • Virtu Financial first reported a position in Quoin Pharmaceuticals in Q1 2021 and held it in 6 quarters.
  • Virtu Financial's Quoin Pharmaceuticals position peaked at $70K in Q1 2023.
  • 13 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.